GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients
University of Maryland, Baltimore
University of Maryland, Baltimore
Institut Cancerologie de l'Ouest
Institut Bergonié
University of Colorado, Denver
Ethicon, Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
University of Texas Southwestern Medical Center
Stanford University
VPIX Medical
Institut Cancerologie de l'Ouest
Ethicon, Inc.
University of Southern California
University of Washington
Wake Forest University Health Sciences
Institut du Cancer de Montpellier - Val d'Aurelle
Washington University School of Medicine
University of Pennsylvania
Massachusetts General Hospital
University of Southern California
Mayo Clinic
Scripps Translational Science Institute
Hackensack Meridian Health
SafeHeal Inc
Universitair Ziekenhuis Brussel
Weill Medical College of Cornell University
Thomas Jefferson University
Thomas Jefferson University
University of California, San Francisco
Duke University
Thomas Jefferson University
Thomas Jefferson University
Abramson Cancer Center at Penn Medicine
University of Utah
Columbia University
Washington University School of Medicine
OHSU Knight Cancer Institute
University of Colorado, Denver
Mayo Clinic
Indiana University
Wake Forest University Health Sciences
Baptist Health South Florida
Albert Einstein College of Medicine
Wake Forest University Health Sciences
Pfizer
Columbia University
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)